<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AID</journal-id><journal-title-group><journal-title>Advances in Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-2648</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aid.2024.141001</article-id><article-id pub-id-type="publisher-id">AID-130376</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Practice of Infection Prevention and Control Strategies in Risk Departments during the COVID-19 Epidemic
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Minfang</surname><given-names>Wang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wenyi</surname><given-names>Ye</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiefeng</surname><given-names>Huang</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yuexian</surname><given-names>Zhu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xuxia</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hao</surname><given-names>Huang</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fang</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bo</surname><given-names>Jin</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ying</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tieer</surname><given-names>Gan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Medical Department, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, China</addr-line></aff><aff id="aff1"><addr-line>Department of Hospital Infection Control, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, China</addr-line></aff><aff id="aff4"><addr-line>Department of Stomatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China</addr-line></aff><aff id="aff6"><addr-line>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China</addr-line></aff><aff id="aff5"><addr-line>Nursing Department, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, China</addr-line></aff><aff id="aff3"><addr-line>Department of Orthopaedics &amp;amp; Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, China</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>01</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>1</fpage><lpage>12</lpage><history><date date-type="received"><day>30,</day>	<month>October</month>	<year>2023</year></date><date date-type="rev-recd"><day>5,</day>	<month>January</month>	<year>2024</year>	</date><date date-type="accepted"><day>8,</day>	<month>January</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: To explore the practice and application of infection prevention and control strategies in risk departments during the COVID-19 epidemic, and to formulate the infection prevention and control measures to provide advice and guidance in risk departments. 
  Methods: According to the latest plan of diagnosis and treatment, prevention and control issued by the National Health Commission, expert advice and consensus, combined with the actual situation in our hospital, a series of infection prevention and control measures of COVID-19 in risk department was formulated. 
  Results: During the epidemic period, the prevention and control measures of nine risk departments including emergency operation, anesthesiology, endoscopy center, blood purification center, otolaryngology, stomatology, medical imaging department, medical cosmetology department and pulmonary function room were established from six aspects, including pre-examination and screening, medical technology control, personnel management, personal protection, environmental disinfection, medical waste disposal, etc. 
  Conclusion: During the epidemic period, the infection prevention and control strategy of risk departments is one of the key links to control the spread of the epidemic, and risk departments must pay attention to and strictly implement various infection prevention and control measures.
 
</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd> Risk Department</kwd><kwd> Infection Prevention and Control</kwd><kwd> Strategy</kwd><kwd> Practice</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>In recent years, there have been recurring public health events such as seasonal influenza, new coronavirus pneumonia, and monkeypox. These events have had a significant impact, lasting for extended periods, and have presented challenges in terms of prevention, control, and public crisis management [<xref ref-type="bibr" rid="scirp.130376-ref1">1</xref>] . The outbreak of Corona Virus Disease 2019 (COVID-19) has rapidly spread worldwide. Its strong capacity and wide range of transmission have posed a great threat to global public health security [<xref ref-type="bibr" rid="scirp.130376-ref2">2</xref>] . This epidemic has severely hampered global economic and social development, causing extensive damage and far-reaching consequences for the world. It can be considered a serious disaster for humanity as a whole [<xref ref-type="bibr" rid="scirp.130376-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.130376-ref4">4</xref>] . Therefore, our attention is focused on finding scientific and accurate approaches for its prevention and control.</p><p>During the period when COVID-19 was classified as a Class B infectious disease and managed according to the Class A infectious disease, the flow of people in the hospital has increased significantly, and the risk of cluster infection has also increased due to the resumption of work and school. This increase in flow also led to an increased risk of cluster infections. In many areas, cluster epidemics have occurred, with the majority of nosocomial infections happening in general wards rather than fever clinics and isolation wards. In order to effectively prevent and control hospital infections during the COVID-19 epidemic, it is crucial to establish a comprehensive and rational prevention and control system process [<xref ref-type="bibr" rid="scirp.130376-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.130376-ref6">6</xref>] . Therefore, apart from fever clinics, isolation and observation wards, and critical isolation wards, it is important to focus on infection prevention and control measures in other departments such as operating rooms (emergency), anesthesiology departments, endoscopy centers, blood purification centers, otolaryngology departments, dental departments, medical beauty centers, and pulmonary function rooms. These departments have a higher risk of infection due to the nature of their diagnosis and treatment. To ensure effective prevention and control, we have formulated infection prevention and control strategies for these high-risk departments during the COVID-19 epidemic. In this article, based on the diagnosis, treatment, prevention and control plans issued by the National Health Commission, expert guidelines, suggestions, and consensus, as well as our own experiences in epidemic prevention and control [<xref ref-type="bibr" rid="scirp.130376-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.130376-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.130376-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.130376-ref10">10</xref>] , these strategies were designed to benefit everyone.</p></sec><sec id="s2"><title>2. Practice of Prevention and Control Strategies in Risk Departments</title><p>This article focuses on the implementation of prevention and control strategies in various risk departments, such as operating rooms (emergency), anesthesiology departments, endoscopy centers, blood purification centers, otolaryngology departments, stomatology departments, medical imaging departments, medical beauty centers, and pulmonary function rooms. The protection levels in these departments are categorized into three levels: first-level protection (associated with low risk), second-level protection (associated with high risk), and third-level protection (associated with extremely high risk) [<xref ref-type="bibr" rid="scirp.130376-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.130376-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.130376-ref12">12</xref>] .</p><sec id="s2_1"><title>2.1. Prevention and Control Measures in Operating Rooms (Emergency) during the COVID-19 Epidemic (Operating Rooms, Interventional Departments)</title><p>Pre-operative screening (<xref ref-type="fig" rid="fig1">Figure 1</xref>): 1) Conduct blood routine, CT examination, new coronavirus nucleic acid and antibody testing before surgery, and consult and evaluate by an expert panel. 2) Patients who have not been consulted by the expert group should be treated as suspected COVID-19 cases and undergo surgery in a dedicated negative pressure operating room or a relatively independent (endmost) operating room with an independent purification system [<xref ref-type="bibr" rid="scirp.130376-ref13">13</xref>] . Medical technology control: a) Strictly implement time-based and orderly opening, control the number of surgeries, and arrange them at staggered times. b) Reduce the patient’s stay in the operating room. c) Prioritize high-quality surgeries.</p><p>Personnel management: Personnel not related to the operation are not allowed to enter the operating room. Personal protection (<xref ref-type="table" rid="table1">Table 1</xref>): 1) Implement standard precautions when COVID-19 is ruled out. 2) In cases where COVID-19 cannot be ruled out, implement third-level protection, including postoperative transportation.</p><p>Disposal of reusable items: The use of disposable instruments and items should still be recommended for COVID-19 patients. After cleaning the blood stains from the reused equipment, they should be soaked in a 1000 mg/L chlorine-containing disinfectant for 30 minutes. Then, they should be placed in a double-layer special garbage bag, securely tied, and labeled as “COVID-19” on the outside. These bags should be placed in a designated area for “special infection equipment” and recycled separately using the designated routes [<xref ref-type="bibr" rid="scirp.130376-ref14">14</xref>] .</p><p>Disinfection of lead clothing: The lead clothing used during operations should be wiped and disinfected with disinfectant wipes containing quaternary ammonium salts for 30 minutes. Then, it should be hung to dry naturally before reuse.</p></sec><sec id="s2_2"><title>2.2. Prevention and Control Measures for Anesthesiology Departments during the COVID-19 Epidemic</title><p>Pre-operative screening involves collecting the patient’s epidemiological history and clinical manifestations, as well as conducting blood routine and lung CT</p><p>examinations [<xref ref-type="bibr" rid="scirp.130376-ref15">15</xref>] . Patients with an epidemiological history or those who require intubation due to respiratory failure should undergo the following screening procedures: being treated as suspected COVID-19 cases.</p><p>In terms of medical technology control, the number of surgeries should be regulated.</p><p>Personal protection measures should be implemented, as outlined in <xref ref-type="table" rid="table1">Table 1</xref>. Standard precautions should be followed if COVID-19 is excluded, while third-level protection should be implemented when COVID-19 cannot be ruled out.</p><p>In terms of surface disinfection, after tracheal intubation in the general ward, the surface of carried items should be wiped and disinfected using quaternary ammonium salt disinfectant wipes or 75% alcohol wipes. When tracheal intubation is performed in the isolation ward or fever clinic, the required items and equipment should be left in the intubation area, and terminal disinfection should be conducted based on the surface of items in this area.</p></sec><sec id="s2_3"><title>2.3. Prevention and Control Measures of the Endoscopy Center during the COVID-19 Epidemic</title><p>Pre-screening: Inquire about the individual’s epidemiological history, take their body temperature, verify their health code, and conduct a lung CT scan, blood routine, and COVID-19 antibody test to determine if they are suspected COVID-19 cases.</p><p>Medical technology control: strictly adhere to the appointment system. 1) To establish dedicated diagnosis and treatment rooms for patients who have not been ruled out for COVID-19 or who still have a fever after being ruled out for COVID-19. 2) For patients undergoing anesthesia, ensure that resuscitation is completed in a single room and wearing a medical surgical mask when conditions allow. 3) All diagnosis and treatment rooms should be used by only one person and should be thoroughly disinfected.</p><p>Personnel management: To limit the number of individuals in the diagnosis and treatment room to the minimum required personnel [<xref ref-type="bibr" rid="scirp.130376-ref16">16</xref>] ; to strictly enforce the one-patient-one-accompaniment system in the waiting area; to require each patient to disinfect their hands with quick-drying hand disinfectant before entering the endoscopy center.</p><p>Personal protection (<xref ref-type="table" rid="table1">Table 1</xref>): to implement standard precautions at the appointment desk; to apply first-level protection in the diagnosis rooms, treatment rooms and decontamination rooms.</p></sec><sec id="s2_4"><title>2.4. Prevention and Control Measures of the Blood Purification Center during the COVID-19 Epidemic</title><p>Pre-screening: complete the epidemiological survey form and monitor body temperature. If COVID-19 cannot be ruled out, conduct two checks for new coronavirus nucleic acid results.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> List of protection classification and material allocation for different risk departments</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Risk Department</th><th align="center" valign="middle" >Protection level</th><th align="center" valign="middle" >Suggestions on the allocation of protective materials</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Operating room (emergency), anesthesiology department</td><td align="center" valign="middle" >COVID-19 has been ruled out</td><td align="center" valign="middle" >Standard precautions</td><td align="center" valign="middle" >Disposable work caps, medical surgical masks, work clothes, disposable sterile surgical gowns, gloves, quick-drying hand disinfectants, and disinfectant wipes.</td></tr><tr><td align="center" valign="middle" >COVID-19 needs to be checked</td><td align="center" valign="middle" >Level three protection</td><td align="center" valign="middle" >Disposable work caps, medical protective masks, work clothes, goggles, comprehensive respiratory protectors, or positive pressure hoods, protective clothing, gloves (double layer), disposable shoe covers, disposable sterile surgical gowns, quick-drying hand disinfectants and disinfectant wipes are required. Additionally, the interventional department should also wear a full set of lead clothing.</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Endoscopy center</td><td align="center" valign="middle" >Reservation desk</td><td align="center" valign="middle" >Standard precautions</td><td align="center" valign="middle" >Disposable work caps, medical surgical masks, work clothes, gloves, quick-drying hand disinfectants, and disinfectant wipes.</td></tr><tr><td align="center" valign="middle" >Treatment room</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work caps, medical surgical masks, overalls, isolation gowns, gloves, quick-drying hand disinfectants, disinfectant wipes; medical protective masks, goggles or protective visors when necessary.</td></tr><tr><td align="center" valign="middle" >Washroom</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work caps, medical surgical masks, overalls, waterproof isolation gowns, protective masks, gloves, quick-drying hand disinfectants, disinfectant wipes; medical protective masks and goggles if necessary.</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Blood purification center</td><td align="center" valign="middle" >General area</td><td align="center" valign="middle" >Standard precautions</td><td align="center" valign="middle" >Disposable work caps, medical surgical masks, work clothes, isolation gowns, quick-drying hand disinfectants, and disinfectant wipes.</td></tr><tr><td align="center" valign="middle" >Dedicated area</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work caps, medical protective masks, work clothes, isolation gowns, goggles or protective visors, gloves, shoe covers, quick-drying hand disinfectants, and disinfectant wipes.</td></tr><tr><td align="center" valign="middle" >Otolaryngology</td><td align="center" valign="middle" >Daily diagnosis and treatment activities or ward rounds</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work caps, medical protective masks, work clothes, goggles or protective masks, isolation gowns, gloves, quick-drying hand disinfectants, and disinfectant wipes (surgical masks are sufficient for non-aerosol operations).</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Stomatology</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work caps, medical protective masks, work clothes, goggles or protective masks, isolation gowns, gloves, quick-drying hand disinfectants, and disinfectant wipes (surgical masks are sufficient for non-aerosol operations).</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Medical imaging department</td><td align="center" valign="middle" >Special room for fever patients</td><td align="center" valign="middle" >Secondary protection</td><td align="center" valign="middle" >Disposable work caps, medical protective masks, work clothes, goggles or protective masks, isolation gowns, gloves, disposable shoe covers, quick-drying hand disinfectants, and disinfectant wipes.</td></tr><tr><td align="center" valign="middle" >General patient room</td><td align="center" valign="middle" >Standard precautions</td><td align="center" valign="middle" >Disposable work caps, medical surgical masks, work clothes, quick-drying hand disinfectants, and disinfectant wipes.</td></tr><tr><td align="center" valign="middle" >Medical aesthetics department</td><td align="center" valign="middle" >General consulting office</td><td align="center" valign="middle" >Standard precautions</td><td align="center" valign="middle" >Disposable work caps, medical surgical masks, work clothes, quick-drying hand disinfectant, disinfectant wipes; gloves if necessary.</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Medical aesthetics department</td><td align="center" valign="middle" >Close range operation</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work cap, medical surgical mask or medical protective mask, goggles or protective face shield, work clothes, gloves, quick-drying hand disinfectant, disinfectant wipes (When carrying out activities where there is a possibility of being splashed by blood, body fluids, secretions, etc., to wear an impermeable isolation gown).</td></tr><tr><td align="center" valign="middle" >Operation</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work caps, medical protective masks, goggles or protective visors, work clothes, disposable sterile isolation gowns, gloves, quick-drying hand disinfectants, and disinfectant wipes.</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Pulmonary function department</td><td align="center" valign="middle" >Level 1 protection</td><td align="center" valign="middle" >Disposable work caps, medical protective masks, goggles or protective face shields, isolation gowns, gloves, quick-drying hand disinfectants, and disinfectant wipes (surgical masks are sufficient for non-aerosol operations).</td></tr></tbody></table></table-wrap><p>Medical technology control: For patients with a new onset of the disease, it is recommended to undergo peritoneal dialysis treatment first, unless there are absolute contraindications [<xref ref-type="bibr" rid="scirp.130376-ref17">17</xref>] .</p><p>Personnel management: 1) Patients must perform hand disinfection before entering the blood purification center and wear medical surgical masks throughout the process. Family members are not allowed to enter the blood purification center. 2) Patients with green cards, who have returned to Hangzhou from other places and have ruled out COVID-19 but still have fever, can enter the general area for dialysis treatment after being treated in a dedicated area (the end partition area) for 2 weeks and showing no abnormal symptoms. 3) Staff in general areas and dedicated areas should not be shared.</p><p>Personal protection (<xref ref-type="table" rid="table1">Table 1</xref>): Standard precautions should be implemented in general areas, while first-level protection should be implemented in dedicated areas.</p></sec><sec id="s2_5"><title>2.5. Otolaryngology Prevention and Control Measures during the COVID-19 Epidemic</title><p>Pre-examination screening includes the responsibility system of first-diagnosis, inquiry about epidemiological history, and assessment of epidemic risks. CT scans and COVID-19 nucleic acid testing are conducted as necessary to enhance the ability to identify and diagnose diseases.</p><p>In terms of medical technology control, measures such as reducing the admission of non-emergency patients and suspending high-risk diagnostic and treatment procedures are implemented. These high-risk procedures include negative pressure nasal replacement surgery, video nasal endoscopy, video laryngoscopy, hearing-related tests, and indirect laryngoscopy [<xref ref-type="bibr" rid="scirp.130376-ref18">18</xref>] . Upon downgrading to level three response, certain diagnostic and treatment procedures like hearing-related tests, indirect laryngoscopy, and video laryngoscopy will gradually resume. However, for invasive operations like nasal negative pressure replacement surgery, it is mandatory to complete new coronavirus nucleic acid testing and antibody testing, and additional tests such as lung CT may be performed depending on the condition.</p><p>Personnel management involves strictly implementing the “one person, one clinic” system.</p><p>Personal protection should follow first-level protection measures as outlined in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s2_6"><title>2.6. Dental Prevention and Control Measures during the COVID-19 Epidemic</title><p>Pre-examination screening includes asking for epidemiological history, seeing a doctor with a green code, and performing a lung CT examination before undergoing a turbine operation. Medical technology control involves strengthening the appointment system. For level, 1 - 2 responses, high-risk projects such as elective surgeries, complex tooth extractions, crown and bridge repairs that require tooth preparation, and scaling should be suspended [<xref ref-type="bibr" rid="scirp.130376-ref19">19</xref>] . After downgrading to level 3 response, invasive operations such as dental implant surgeries, complex tooth extractions, ultrasonic tooth cleaning, and minor outpatient surgeries in the dental department are allowed. However, before the operation, patients must first complete the COVID-19 nucleic acid test and antibody test, and undergo a lung CT if necessary. Only those with negative COVID-19 nucleic acid and antibody test results can make an appointment with a doctor for treatment.</p><p>Personnel management should strictly implement the “one person, one clinic” system with 15 minutes between patients and 30 minutes between turbine operations.</p><p>Personal protection should follow first-level protection measures (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s2_7"><title>2.7. Medical Imaging Department of CT Examination Prevention and Control Procedures during the COVID-19 Epidemic</title><p>Medical technology control: to establish a dedicated computer room for patients with fever, COVID-19 waiting list, or suspected COVID-19 cases.</p><p>Personnel management: implement a strict examination calling system to control the flow of people for examination and the number of people waiting for treatment.</p><p>Personal protection (<xref ref-type="table" rid="table1">Table 1</xref>): to implement secondary protection in dedicated computer rooms for heating, and standard precautions in ordinary computer rooms.</p><p>Environmental disinfection management of the fever-specific computer room: Before the patient enters, the technician activates the air disinfection machine, sets up the position, and waits in the corridor outside the computer room. After the examination, the technician uses quaternary ammonium salt disinfectant wipes to clean and disinfect the equipment and surfaces in the computer room. Additionally, air disinfection continues for 30 minutes, ensuring one person, one use, and one disinfection.</p></sec><sec id="s2_8"><title>2.8. Prevention and Control Measures for Medical Aesthetics Departments during the COVID-19 Epidemic</title><p>Pre-examination screening involves asking about the epidemiological history, checking the health code and valid certificates, and measuring body temperature.</p><p>In terms of medical technology control, before carrying out invasive diagnosis and treatment procedures such as eye plastic surgery, rhinoplasty, liposuction, and body surface tumors, it is mandatory to conduct COVID-19 nucleic acid testing and antibody testing. When hospitalization is required for diagnosis and treatment procedures, a lung CT examination must be performed.</p><p>Personnel management includes assigning a dedicated person to maintain order in the waiting area and ensuring that patients maintain a safe distance of 1 meter.</p><p>Personal protection measures (<xref ref-type="table" rid="table1">Table 1</xref>): First-level protection is implemented during close operations and surgeries, while standard precautions are implemented in general clinics.</p></sec><sec id="s2_9"><title>2.9. The Examination and Prevention and Control Measures of Pulmonary Function Room during the COVID-19 Epidemic</title><p>Pre-examination screening is conducted to gather information about patients’ epidemiological history and clinical manifestations, in order to exclude suspected cases.</p><p>In terms of medical technology control, pulmonary function tests are not conducted on confirmed or suspected patients. Outpatients with fever and respiratory symptoms can only be tested after specialists or fever clinics rule out the possibility of new coronavirus pneumonia [<xref ref-type="bibr" rid="scirp.130376-ref20">20</xref>] .</p><p>Personal protection measures should be implemented at the first level (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s2_10"><title>2.10. Environmental Disinfection of Risk Departments during the COVID-19 Epidemic</title><p>According to the guidelines which are set forth in the Technical Specifications for Disinfection of Medical Institutions, we carry out cleaning and disinfection, including cleaning and disinfecting medical equipment, contaminated items, object surfaces, and floors. Additionally, air disinfection is conducted in accordance with the Hospital Air Purification Management Specifications [<xref ref-type="bibr" rid="scirp.130376-ref10">10</xref>] .</p><p>For environmental surface disinfection, it is recommended to use a chlorine-containing disinfectant with a concentration of 500 - 1000 mg/L. If the surface is not corrosion-resistant, quaternary ammonium salt disinfectant wipes or 75% alcohol can be used instead. In case of contamination with blood or body fluids, it is advisable to first remove the contaminants with a dry towel and then proceed to wipe and disinfect using a chlorine-containing disinfectant with a concentration of 2000 mg/L or disinfectant wipes. (2) For air disinfection, it is recommended to ensure good natural ventilation in a room by opening windows at least three times a day for a minimum of 15 minutes each time. In areas with poor natural ventilation, the use of an air disinfection machine is recommended [<xref ref-type="bibr" rid="scirp.130376-ref21">21</xref>] .</p></sec><sec id="s2_11"><title>2.11. Medical Waste Management in Risk Departments during the COVID-19 Epidemic</title><p>Medical waste generated by patients suspected of or pending novel coronavirus pneumonia must comply with the requirements of Medical Waste Management Regulations and Medical Waste Management Measures for Medical and Health Institutions. To properly load the medical waste, it is recommended to use double-layer packaging bags and secure them with a gooseneck knot. Additionally, the packaging bags should be sealed in layers and the surface should be sprayed and disinfected with a chlorine-containing disinfectant with a concentration of 1000 mg/L before leaving the contaminated area (ensuring even spraying). Alternatively, an additional layer of medical waste packaging bag can be added outside the original bag [<xref ref-type="bibr" rid="scirp.130376-ref22">22</xref>] .</p></sec></sec><sec id="s3"><title>3. Summary</title><p>During COVID-19 epidemic, risk departments play a crucial role in infection prevention and control. The scientific, accurate, reasonable, and feasible processes are developed to prevent and control infections within the risk department. These measures are strictly implemented to ensure the successful execution of prevention and control work during the COVID-19 epidemic, reducing the risk of exposure for all hospital personnel. It is essential to focus on both “external prevention of input” and “internal prevention of spreading” [<xref ref-type="bibr" rid="scirp.130376-ref23">23</xref>] . This involves implementing pre-screening and screening processes and managing outpatient and emergency patients, their families, and all hospital personnel at various levels. As our understanding of COVID-19 deepens and our experience in diagnosis and treatment accumulates, the hospital’s prevention and control strategies and management methods will be adjusted accordingly. By summarizing our experience in combating the epidemic, we can develop practical, effective, economical, and appropriate prevention and control plans. These plans can serve as solutions for China and the world in dealing with infectious diseases of this scale and nature [<xref ref-type="bibr" rid="scirp.130376-ref24">24</xref>] .</p></sec><sec id="s4"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec id="s5"><title>Cite this paper</title><p>Wang, M.F., Ye, W.Y., Huang, J.F., Zhu, Y.X., Yu, X.X., Huang, H., Xu, F., Jin, B., Fu, E.Q., Yang, Y. and Gan, T.E. (2024) Practice of Infection Prevention and Control Strategies in Risk Departments during the COVID-19 Epidemic. Advances in Infectious Diseases, 14, 1-12. https://doi.org/10.4236/aid.2024.141001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.130376-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names> X. </given-names></name>,<etal>et al</etal>. (<year>2023</year>)<article-title>Principles and Optimization Strategies for Public Opinion Response to Public Health Events—Taking the Investigation of COVID-19 Epidemic Prevention and Control as an Example</article-title><source> Journal of Shaanxi University of Science and Technology (Social Science Edition)</source><volume> 41</volume>,<fpage> 26</fpage>-<lpage>34</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.130376-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mahase, E. (2020) Covid-19: UK Records First Death, as World’s Cases Exceed 100 000. BMJ, 368, m943. &lt;/br&gt;https://doi.org/10.1136/bmj.m943</mixed-citation></ref><ref id="scirp.130376-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, R. (2023) Research on the Basic Experience of my Country’s New Crown Epidemic Prevention and Control. Master’s Thesis, Lanzhou University of Finance and Economics, Lanzhou.</mixed-citation></ref><ref id="scirp.130376-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Du, Y. (2022) Research on COVID-19 Epidemic Prevention and Control Strategies Based on Infectious Disease Models and Statistical Analysis Methods. Ph.D. Thesis, Hunan Normal University, Zhengzhou.</mixed-citation></ref><ref id="scirp.130376-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, V., Wong, S., Chen, J., et al. (2020) Escalating Infection Control Response to the Rapidly Evolving Epidemiology of the Coronavirus Disease 2019 (COVID-19) Due to SARS-CoV-2 in Hong Kong. Infection Control &amp; Hospital Epidemiology, 41, 493-498. &lt;/br&gt;https://doi.org/10.1017/ice.2020.58</mixed-citation></ref><ref id="scirp.130376-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yao, H., Suo, J., Xing, Y., et al. (2018) Investigation and Analysis of the Current Situation of Hospital Infection Management and Prevention and Control in my Country. Chinese Journal of Hospital Infection, 28, 1563-1568.</mixed-citation></ref><ref id="scirp.130376-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">General Office of National Health Commission and Office of National Administration of Traditional Chinese Medicine (2020) Diagnosis and Treatment Plan for COVID-19 (Trial Version 7). National Health Office Medical Letter No. 184.</mixed-citation></ref><ref id="scirp.130376-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">General Office of National Health Commission (2020) Technical Guidelines for the Prevention and Control of COVID-19 Infection in Medical Institutions (First Edition). National Health Office Medical Letter No. 65.</mixed-citation></ref><ref id="scirp.130376-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Office of the National Administration of Traditional Chinese Medicine and General Office of the National Health Commission (2020) Technical Guidelines for the Protection of Medical Personnel during the COVID-19 Epidemic (Trial). National Health Office Medical Letter No. 155.</mixed-citation></ref><ref id="scirp.130376-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">General Office of the National Health Commission (2020) COVID-19 Prevention and Control Plan (Fifth Edition). National Health Office Medical Letter No. 156.</mixed-citation></ref><ref id="scirp.130376-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">National Health and Family Planning Commission and People’s Republic of China (2017) Standards for Hospital Infection Prevention and Control of Airborne Diseases: WS/T511-2016. Chinese Journal of Infection Control, 16, 490-492.</mixed-citation></ref><ref id="scirp.130376-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Li, C., Huang, X., Cai, Y., et al. (2020) Expert Consensus on Personal Protection in Different Areas of Medical Institutions during the COVID-19 epidemic. Chinese Journal of Infection Control, 19, 199-213.</mixed-citation></ref><ref id="scirp.130376-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Li, X., Wang, Qi., et al. (2020) Understanding and Thinking on Perioperative Management and Protection of Patients with New Coronavirus Pneumonia. Chinese Journal of General Surgery, 29, 1-5.</mixed-citation></ref><ref id="scirp.130376-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Chinese Nursing Association, Disinfection Supply Center and Nursing Professional Committee (2020) Guidelines and Recommendations for the Disposal Process of Reused Medical Devices and Objects for Patients with Suspected or Confirmed COVID-19.</mixed-citation></ref><ref id="scirp.130376-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Anesthesiology Branch of the Chinese Medical Association (2020) Recommendations on Routine Surgical Anesthesia Management and Prevention and Control Procedures during the COVID-19 Epidemic.</mixed-citation></ref><ref id="scirp.130376-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Digestive Endoscopy of Chinese Medical Association (2020) Guiding Opinions on Diagnosis and Treatment of Digestive Endoscopy during the Prevention and Control of COVID-19.</mixed-citation></ref><ref id="scirp.130376-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">National Center for Quality Control of Kidney Disease (2020) Expert Recommendations on Prevention and Control of COVID-19 Infection in Hemodialysis Units (Centers).</mixed-citation></ref><ref id="scirp.130376-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Otolaryngology Branch of Chinese Association of Traditional Chinese Medicine (2020) Expert Recommendations on Otolaryngology Diagnosis and Treatment from Traditional Chinese Medicine (Integrated Traditional Chinese and Western Medicine) during the COVID-19 Epidemic.</mixed-citation></ref><ref id="scirp.130376-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Zhejiang Provincial Health Commission (2020) Notice of the Zhejiang Provincial Health Commission on the Orderly Resumption of Dental and Other Medical Services.</mixed-citation></ref><ref id="scirp.130376-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Li. L., Song, Y., Jin, M. and Pulmonary Function Group of Respiratory Disease Branch of Shanghai Medical Association (2020) Expert Consensus on Preventing Cross-Infection of Pulmonary Function Tests during the Prevention and Control of New Coronavirus Pneumonia. Chinese Clinical Medicine, 27, 20-22.</mixed-citation></ref><ref id="scirp.130376-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">People’s Republic of China Health Industry Standard (2012) Regulation of Disinfection Technique in Healthcare Settings, WS367-2012.</mixed-citation></ref><ref id="scirp.130376-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">General Office of the National Health Commission (2020) Notice of the General Office of the National Health Commission on the Management of Medical Waste in Medical Institutions during the COVID-19 Epidemic. National Health Office Medical Letter No. 81.</mixed-citation></ref><ref id="scirp.130376-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Du, M., Suo, J., Yan, Z., et al. (2020) Infection Prevention and Control Strategies in Large Comprehensive Hospitals during the Epidemic of New Coronavirus Infection. Chinese Journal of Hospital Infectious Diseases, 30, 1131-1134.</mixed-citation></ref><ref id="scirp.130376-ref24"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fu</surname><given-names> Q. </given-names></name>,<etal>et al</etal>. (<year>2020</year>)<article-title>Practical Thoughts on Infection Prevention and Control in Medical Institutions Based on COVID-19 Epidemic Response</article-title><source> Chinese Journal of Hospital Infectious Diseases</source><volume> 30</volume>,<fpage> 1121</fpage>-<lpage>1124</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref></ref-list></back></article>